3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
19
Colonic Neoplasms
9
Pancreatic Neoplasms
8
Stomach Neoplasms
7
Esophageal Neoplasms
7
Adenocarcinoma Of Esophagus
6
Rectal Neoplasms
5
Neoplasm Metastasis
5
Cholangiocarcinoma
5
Ovarian Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Carcinoma, Non-Small-Cell Lung
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Endometrial Neoplasms
3
Biliary Tract Neoplasms
3
Adenocarcinoma
3
Recurrence
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Oxaliplatin
×
30 days
×
Clear all
No trials found.